Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

Bodyport Inc., a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.

News | Cardiovascular Clinical Studies

Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference

March 6, 2024 — Bodyport Inc., a biomarker-guided predictive care company focused on heart failure, announced data from ...

March 06, 2024

Feature | PACS | By Melinda Taschetta-Millane

The Emergence of Cloud-based PACS, and Other Trends

Picture archiving and communication systems (PACS) play a crucial role in modern radiology by providing a digital ...

March 06, 2024

Feature

One on One ... with Hal Wolf, FHIMSS

Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management Systems ...

March 06, 2024

During the upcoming Healthcare Information and Management Systems Society Global Conference and Exhibition, HIMSS24, experts from the world’s largest government agencies will convene to focus on the future of public healthcare and the regulation of artificial intelligence (AI) and other emerging trends.

News | HIMSS

Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

March 6, 2024 — This year’s Healthcare Information and Management Systems Society HIMSS Global Conference and Exhibition ...

March 05, 2024

Maternal stress may lead to adverse changes in mental, physical health that impact development of the fetal heart

News | Pediatric Cardiology

Severe Maternal Grief Associated with Increased Risk of Heart Failure in Child

March 1, 2024 — Prenatal stress is a potential risk factor for cardiovascular disease in offspring later in life. In a ...

March 01, 2024

Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.

News | ACC

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific Session ...

February 29, 2024

American Heart Association’s first scientific statement on artificial intelligence (AI) underscores value of technology’s new clinical insights on CVD patient outcomes

News | Artificial Intelligence

Urgent Need to Develop Best Practices to Advance Use of AI in Cardiovascular Care

February 28, 2024 — Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many challenges ...

February 28, 2024

The academic medical centers earned distinguished three-star ratings from The Society of Thoracic Surgeons (STS) for their patient care and outcomes in adult cardiac surgery

News | Cardiovascular Surgery

Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

February 26, 2024

Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery disease (CAD), allowing for reclassification to a lower disease category in 54% of patients

News | Computed Tomography (CT)

Photon-Counting CT Improves Coronary Artery Disease Assessment

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

February 20, 2024

Research findings in a clinical trial led by a professor at the University of Tennessee Health Science Center’s College of Nursing are likely to dramatically change care and improve outcomes for patients suffering from acute stroke.

News | Stroke

ZODIAC Clinical Trial Led by UT Health Science Center Professor Likely to Make Major Impact on Stroke Care

February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...

February 15, 2024

NCDR’s CV ASC Registry Suite follows increases in ambulatory cardiac procedures, provides benchmarks

News | ACC

First-of-its-kind ACC Registry Tracks Cardiac Procedures Performed in Ambulatory Surgical Settings

February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac ...

February 14, 2024

The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or high blood pressure, in older adults without increasing their risk of low blood pressure episodes, according to a study published in the Feb. 2024 issue of the Journal of the American College of Cardiology (JACC).

News | Hypertension

DECIDE-Salt Study Finds Salt Substitutes Help to Maintain Healthy Blood Pressure in Older Adults

February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or ...

February 14, 2024

BIOTRONIK, a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward

News | Implantable Cardioverter Defibrillator (ICD)

The Future of Single Chamber ICDs: BIOTRONIK Takes Unprecedented Market Stance with Proprietary DX Technology

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

February 12, 2024

Results show statistically significant decreases in stroke volume, edema, and necrotic area versus controls

News | Stroke

VST BIO Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Monoclonal Antibody to Treat Ischemic Stroke at AHA International Stroke Conference

February 12, 2024 — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic cardiov ...

February 12, 2024

On the final day of the American Stroke Association’s International Stroke Conference 2024, ISC 2024, findings from the EMBOLISE clinical trial were presented by Jason Davies, M.D., Ph.D., an associate professor in the departments of neurosurgery and biomedical informatics at the State University of New York, Buffalo.

News | AHA

ISC 2024 News: Late-Breaking Science Findings from EMBOLISE Clinical Trial Reveals Blocking Artery Supplying the Brain Covering After Subdural Hematoma Reduced Repeat Surgery

February 9, 2024 — Injection of a substance to block an artery feeding the dura (protective sack around the brain) — ...

February 09, 2024